Cell line name |
SKOV3/VP |
Accession |
CVCL_Y280 |
Resource Identification Initiative |
To cite this cell line use: SKOV3/VP (RRID:CVCL_Y280) |
Comments |
Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16). Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. |
Sequence variations |
- Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
|
Disease |
Ovarian serous cystadenocarcinoma (NCIt: C7978) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0532 (SK-OV-3) |
Sex of cell |
Female |
Age at sampling |
64Y |
Category |
Cancer cell line |
Publications | PubMed=7911742; DOI=10.1007/BF00685075 Kubota N., Nishio K., Takeda Y., Ohmori T., Funayama Y., Ogasawara H., Ohira T., Kunikane H., Terashima Y., Saijo N. Characterization of an etoposide-resistant human ovarian cancer cell line. Cancer Chemother. Pharmacol. 34:183-190(1994) PubMed=14973057; DOI=10.1158/0008-5472.CAN-3263-2 Yasui K., Mihara S., Zhao C., Okamoto H., Saito-Ohara F., Tomida A., Funato T., Yokomizo A., Naito S., Imoto I., Tsuruo T., Inazawa J. Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res. 64:1403-1410(2004) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_Y280
CGH-DB; 9125-4
|
Encyclopedic resources |
Wikidata; Q54954774
|
Entry history |
Entry creation | 07-Nov-2014 |
Last entry update | 19-Dec-2024 |
Version number | 18 |
---|